BioCentury
ARTICLE | Company News

Catalent Pharma, Redwood Bioscience deal

April 15, 2013 7:00 AM UTC

Redwood granted Catalent exclusive rights to market antibody-drug conjugate (ADC) therapies using Redwood's SMARTag technology. Catalent took an undisclosed minority stake in Redwood, which may increa...